Digital mammography alliance goes through
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around Hologic's flat-panel amorphous selenium technology but will include Agfa image processing and information technology. The Joint Development and OEM Purchase Agreement is an outgrowth of a Letter of Intent signed by the two companies in April 2002.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
